GlassScriptPhysician profile
Binita Shah
NPI 1801093596
$59,475.66
in general payments reported to CMS, 2019-2025
17 companies · $663 in 2025
The $663 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,357 · 2020: $1,761 · 2021: $14K · 2022: $15K · 2023: $10K · 2024: $10K · 2025: $663.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Food and Beverage: $2,900 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $2,125 · Travel and Lodging: $1,946 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,800.00 |
| Food and Beverage | $2,900.32 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $2,125.00 |
| Travel and Lodging | $1,946.12 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $31,708.00 | 2020-2024 | (9520) Igt Devices Undivided, (Bh4) Igt Devices Undivided |
| Horizon Therapeutics Plc | $11,095.39 | 2020-2022 | |
| Radux Devices LLC | $5,333.00 | 2019 | |
| Terumo Medical Corporation | $3,516.77 | 2019-2023 | Heartrail, Glidewire |
| Shockwave Medical, INC | $2,507.45 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $2,099.38 | 2019-2025 | Impella |
| Boston Scientific Corporation | $1,365.49 | 2022-2025 | Avvigo Guidance System, Synergy |
| Magenta Medical INC | $500.00 | 2024 | |
| Abbott Laboratories | $439.78 | 2019-2025 | Dragonfly Opstar, Navitor |
| Edwards Lifesciences Corporation | $186.79 | 2022 | |
| Medtronic, INC. | $182.81 | 2022-2024 | Symplicity G3, Onyx Frontier |
| Recor Medical INC | $158.37 | 2025 | Paradise Ultrasound Renal Denervation System |
| Chiesi USA, INC. | $146.64 | 2019-2025 | Kengreal |
| Astrazeneca Pharmaceuticals LP | $109.17 | 2019 | |
| Novo Nordisk INC | $88.30 | 2023-2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $32.19 | 2025 | |
| Penumbra, INC. | $6.13 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Binita Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.